Delavirdine
Back to searchMolecule Structure
Scientific Name
Delavirdine
Description of the Drug
Delavirdine is a non-nucleoside reverse transcriptase inhibitor used to treat HIV infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00705
http://www.drugbank.ca/drugs/DB00705
Brand Name(s)
Not Available
Company Owner(s)
Viiv Healthcare Co
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase | SINGLE PROTEIN | INHIBITOR | CHEMBL247 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34420 | ||
| PharmGKB | PA449223 | ||
| Human Metabolome Database | HMDB0014843 | ||
| DrugBank | DB00705 | ||
| PubChem: Thomson Pharma | 14857955 | ||
| PubChem | 5625 | ||
| LINCS | LSM-46198 | ||
| Nikkaji | J571.558J | ||
| PDBe | SPP | ||
| BindingDB | 1944 | ||
| EPA CompTox Dashboard | DTXSID6022892 | ||
| DrugCentral | 799 | ||
| Brenda | 165909 | ||
| ChemicalBook | CB8292151 | ||
| rxnorm | DELAVIRDINE | RESCRIPTOR | DELAVIRDINE MESYLATE |
| KEGG Ligand | C06941 | ||
| ChEBI | 119573 | ||
| ZINC | ZINC000018516586 |
